Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy

被引：0
|
作者：
Ghaly, Simon [1 ,2 ]
Gill, Raghubinder S. [3 ]
Keegan, Mathew J. [3 ]
Angus, Peter W. [4 ]
George, Jacob [5 ,6 ]
Nicoll, Amanda J. [7 ]
Law, Matthew [8 ]
Sinclair, Marie [9 ]
Lim, Lucy Y. [4 ]
Ratnayake, Hasanka [7 ]
Dunn, Anna [7 ]
Strasser, Simone I. [3 ]
Zekry, Amany [1 ,2 ]
机构：
[1] St George Hosp, Sydney, NSW, Australia
[2] St George Hosp, Sydney, NSW, Australia
[3] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia
[4] Austin Hosp, Gastroenterol & Liver Transplant Unit, Melbourne, Vic 3084, Australia
[5] Westmead Hosp, Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia
[6] Univ Sydney, Sydney, NSW 2006, Australia
[7] Royal Melbourne Hosp, Melbourne, Vic, Australia
[8] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia
[9] Monash Med Ctr, Melbourne, Vic, Australia
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
332
引用
下载
收藏
页码：354A / 354A
页数：1
相关论文
共 50 条
  • [1] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B INFECTION AFTER PERSISTENT VIRAL SUPPRESSION WITH ANTIVIRAL THERAPY
    Decharatanachart, Pakanat
    Tangkijvanich, Pisit
    Treeprasertsuk, Sombat
    Rerknimitr, Rungsun
    Chaiteerakij, Roongruedee
    GASTROENTEROLOGY, 2023, 164 (06) : S1363 - S1363
  • [2] Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
    Abdurakhmanov, D. T.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (10): : 94 - 97
  • [3] The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
    Varbobitis, Ioannis
    Papatheodoridis, George V.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 319 - 326
  • [4] Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
    Lee, Minjong
    Chung, Goh Eun
    Lee, Jeong-Hoon
    Oh, Sohee
    Nam, Joon Yeul
    Chang, Young
    Cho, Hyeki
    Ahn, Hongkeun
    Cho, Young Youn
    Yoo, Jeong-ju
    Cho, Yuri
    Lee, Dong Hyeon
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Dong Ho
    Lee, Jeong Min
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2017, 66 (05) : 1556 - 1569
  • [5] Hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment with virological suppression
    Ghaly, S.
    Bu, K.
    Yan, K.
    Choo, L.
    George, J.
    Chu, F.
    Strasser, S.
    Zekry, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 51 - 51
  • [6] Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
    Vlachogiannakos, John
    Papatheodoridis, George
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (47) : 8822 - 8830
  • [7] Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
    John Vlachogiannakos
    George Papatheodoridis
    World Journal of Gastroenterology, 2013, (47) : 8822 - 8830
  • [8] Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis
    Gao, Xuesong
    Yang, Hwai-, I
    Trinh, Huy
    Jeong, Donghak
    Li, Jiayi
    Zhang, Jian
    Le, An
    Hoang, Joseph
    Nguyen, Pauline
    Henry, Linda
    Nguyen, Mindie H.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (09) : 1207 - 1211
  • [9] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B PATIENTS
    Chen, Junjie
    Feng, Tienan
    Zhang, Xinxin
    HEPATOLOGY, 2023, 78 : S491 - S492
  • [10] Does Antiviral Therapy for Chronic Hepatitis B Reduce the Risk of Hepatocellular Carcinoma?
    Abu-Amara, Mahmoud
    Feld, Jordan J.
    SEMINARS IN LIVER DISEASE, 2013, 33 (02) : 157 - 166
12345